Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Samuel J. Haryono"'
Autor:
Ramadhan Karsono, Samuel J. Haryono, Bambang Karsono, Wirsma Arif Harahap, Yulia Pratiwi, Teguh Aryandono
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background The ESR1 gene encodes Estrogen Receptor alpha (ERα), which plays a role in the tumourigenesis of breast cancer. A single nucleotide polymorphism (SNP) in intron 1 of this gene called ESR1 PvuII (rs2234693) has been reported to in
Externí odkaz:
https://doaj.org/article/4a39c18f98344a07a5504eb5c786c838
Autor:
Baitha Palanggatan Maggadani, Yahdiana Harahap, Harmita, Samuel J. Haryono, Christoffel William Putra Untu
Publikováno v:
Heliyon, Vol 7, Iss 6, Pp e07275- (2021)
This research was conducted to develop the Dried Blood Spot (DBS) and Volumetric Absorptive Microsampling (VAMS) method in the analysis of Tamoxifen (TAM) and its metabolites endoxifen (END), 4-hydroxytamoxifen (4-HT), and N-desmethyltamoxifen (NDT)
Externí odkaz:
https://doaj.org/article/4a2c125938c849f3b79f69a96c735669
Autor:
Ricvan Dana Nindrea, Nissa Prima Sari, Wirsma Arif Harahap, Samuel J. Haryono, Hari Kusnanto, Iwan Dwiprahasto, Lutfan Lazuardi, Teguh Aryandono
Publikováno v:
Data in Brief, Vol 32, Iss , Pp 106293- (2020)
This set of data presents a survey data describing multidrug-resistant tuberculosis, tuberculosis patients characteristics and stress resilience during COVID-19 pandemic in West Sumatera Province, Indonesia. The data were gathered from multidrug-resi
Externí odkaz:
https://doaj.org/article/9b070ac11d764f67adc30b020fdca93c
Autor:
Ricvan Dana Nindrea, Nissa Prima Sari, Wirsma Arif Harahap, Samuel J. Haryono, Hari Kusnanto, Iwan Dwiprahasto, Lutfan Lazuardi, Teguh Aryandono
Publikováno v:
Data in Brief, Vol 32, Iss , Pp 106145- (2020)
This dataset presents a survey data describing COVID-19 awareness, knowledge, preparedness and related behaviors among breast cancer patients in Indonesia. The data were collected from breast cancer patients through a survey distributed by an online
Externí odkaz:
https://doaj.org/article/da32cda7212746d296886a9a6e3f4700
Autor:
Samuel J. Haryono
Publikováno v:
Majalah Kedokteran Andalas, Vol 37, Iss 0 (2014)
Selama dua dekade terakhir, pemahaman terhadap kanker yang bersifat herediter mengalamikemajuan yang cukup pesat. Dari seluruh jenis kanker, hanya sekitar 5-1O% yang diturunkan,dan sebagian besar mempunyai pola pewarisan autosomal dominan. Kelainan g
Externí odkaz:
https://doaj.org/article/89eab24dede94552a678480be2590aff
Autor:
Baitha Palanggatan Maggadani, Harmita, Tesanika Ribka Joulin Sitorus, Yahdiana Harahap, Samuel J. Haryono
Publikováno v:
International Journal of Applied Pharmaceutics. :112-120
Objective: Tamoxifen (TAM) is a hormonal therapy that is clinically proven to reduce breast cancer recurrence by blocking estrogen receptor, mainly through its active metabolites, 4-hydroxytamoxifen (4HT) and endoxifen (END), which have a higher affi
Autor:
Baitha Palanggatan Maggadani, Kathleen Irena Junusmin, Levana L. Sani, Caroline Mahendra, Margareta Amelia, Gabriella Gabriella, Astrid Irwanto, Alexandre Chan, Harmita Harmita, Yahdiana Harahap, Samuel J. Haryono
PurposeTamoxifen, common adjuvant therapy prescribed in estrogen receptor positive (ER+) breast cancer, is metabolized by CYP2D6 enzyme into endoxifen. The phenotypes of CYP2D6, a highly polymorphic gene, vary from ultrarapid (UM), normal (NM), inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa5d46ed53f7877b872cca992941885a
https://doi.org/10.21203/rs.3.rs-1037721/v1
https://doi.org/10.21203/rs.3.rs-1037721/v1
Autor:
Kathleen Irena Junusmin, Baitha Palanggatan Maggadani, Amelia M, Astrid Irwanto, Levana Sani, Yahdiana Harahap, Caroline Mahendra, Samuel J. Haryono, Gabriella, Harmita
Tamoxifen is a Selective Estrogen-Receptor Modulator (SERM) commonly prescribed for standard of care in estrogen receptor positive (ER+) breast cancer as an adjuvant therapy. Tamoxifen is metabolized by CYP2D6 into its active metabolite, endoxifen, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a3d320ddca406c0d93183178d87244b
https://doi.org/10.1101/2021.06.25.21259564
https://doi.org/10.1101/2021.06.25.21259564
Autor:
Harmita, Samuel J. Haryono, Baitha Palanggatan Maggadani, Marcellino Ryan Rinaldi, Yahdiana Harahap
Publikováno v:
Drug Design, Development and Therapy
Baitha Palanggatan Maggadani,1 Harmita,1 Samuel J Haryono,2 Marcellino Ryan Rinaldi,1 Yahdiana Harahap1 1Faculty of Pharmacy, Universitas Indonesia, Depok, 16424, Indonesia; 2Surgical Oncology Division, MRCCC Siloam Hospital, Jakarta, IndonesiaCorres
Autor:
Wirsma Arif Harahap, Iwan Dwiprahasto, Ricvan Dana Nindrea, Lutfan Lazuardi, Hari Kusnanto, Samuel J Haryono, Nissa Prima Sari, Teguh Aryandono
Publikováno v:
Data in Brief
Data in Brief, Vol 32, Iss, Pp 106145-(2020)
Data in Brief, Vol 32, Iss, Pp 106145-(2020)
This dataset presents a survey data describing COVID-19 awareness, knowledge, preparedness and related behaviors among breast cancer patients in Indonesia. The data were collected from breast cancer patients through a survey distributed by an online